234 related articles for article (PubMed ID: 3422488)
1. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.
Drillien R; Spehner D; Kirn A; Giraudon P; Buckland R; Wild F; Lecocq JP
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1252-6. PubMed ID: 3422488
[TBL] [Abstract][Full Text] [Related]
2. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
Wild TF; Bernard A; Spehner D; Drillien R
J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113
[TBL] [Abstract][Full Text] [Related]
4. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
Galletti R; Beauverger P; Wild TF
Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
[TBL] [Abstract][Full Text] [Related]
5. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.
Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens.
Wild TF; Bernard A; Spehner D; Villeval D; Drillien R
Vaccine; 1993; 11(4):438-44. PubMed ID: 8470428
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
[TBL] [Abstract][Full Text] [Related]
11. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
12. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene.
Yilma T; Hsu D; Jones L; Owens S; Grubman M; Mebus C; Yamanaka M; Dale B
Science; 1988 Nov; 242(4881):1058-61. PubMed ID: 3194758
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
[TBL] [Abstract][Full Text] [Related]
14. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.
Varsanyi TM; Morein B; Löve A; Norrby E
J Virol; 1987 Dec; 61(12):3896-901. PubMed ID: 2960833
[TBL] [Abstract][Full Text] [Related]
15. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
Polack FP; Lee SH; Permar S; Manyara E; Nousari HG; Jeng Y; Mustafa F; Valsamakis A; Adams RJ; Robinson HL; Griffin DE
Nat Med; 2000 Jul; 6(7):776-81. PubMed ID: 10888926
[TBL] [Abstract][Full Text] [Related]
16. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
[TBL] [Abstract][Full Text] [Related]
17. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE
Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884
[TBL] [Abstract][Full Text] [Related]
18. Encephalitis in ferrets caused by a nonproductive strain of measles virus (D.R.) isolated from patient with subacute sclerosing panencephalitis.
Thormar H; Arnesen K; Mehta PD
J Infect Dis; 1977 Aug; 136(2):229-38. PubMed ID: 894077
[TBL] [Abstract][Full Text] [Related]
19. Expression of measles virus antigens in Streptococcus gordonii.
Maggi T; Oggioni MR; Medaglini D; Bianchi Bandinelli ML; Soldateschi D; Wiesmüller KH; Muller CP; Valensin PE; Pozzi G
New Microbiol; 2000 Apr; 23(2):119-28. PubMed ID: 10872681
[TBL] [Abstract][Full Text] [Related]
20. C3d enhancement of neutralizing antibodies to measles hemagglutinin.
Green TD; Newton BR; Rota PA; Xu Y; Robinson HL; Ross TM
Vaccine; 2001 Oct; 20(1-2):242-8. PubMed ID: 11567770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
